Aurobindo Pharma Limited — Updates, 06-05-2026: General Updates

Aurobindo Pharma's Unit-VII (oral solid dosage) passed its US FDA inspection, which is now closed. This positive outcome, after initial observations, reduces regulatory risk and ensures continued market access.